Alisa Kirkin

In a clinical trial, researchers at the Dana-Farber Cancer Institute in Boston, MA, have demonstrated that administering the immunotherapy drug

A new study from Queen Mary University of London (QMUL) has uncovered a link between the number of ribosomal DNA (rDNA) copies in the genome and an increased risk of developing inflammatory diseases.

A Phase III study from The University of Texas MD Anderson Cancer Center has revealed that combining perioperative immunotherapy with chemotherapy

Researchers at the Hunan Normal University in China have discovered that the expression levels of a protein called retinitis pigmentosa GTPase

Researchers at the Institute for the Advanced Study of Human Biology (ASHBi) at Kyoto University have made a breakthrough in understanding the

Scientists from King's College London have made a significant breakthrough in the treatment of aggressive breast cancer by developing a tailored drug that exploits the cancer cells' weaknesses.

Researchers at City of Hope have discovered new biomarkers that could predict kidney failure in patients with type 1 diabetes (T1D), according to a study published today in Science Translational Medicine

Pembrolizumab immunotherapy has led to over 50% of patients with certain genetic profiles being cancer-free after surgery for bowel cancer.

Researchers have uncovered a key mechanism that maintains proper telomere length, involved in cancer and telomere-related disorders.

A recent study led by researchers at Cleveland Clinic has linked the sugar substitute xylitol to an increased risk of heart attack and stroke.